Ramu Yajamana, Xu Yanping, Lu Zhe
Department of Physiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6448-53. doi: 10.1073/pnas.0701354104. Epub 2007 Mar 30.
Numerous mutations in the cystic fibrosis (CF) transmembrane conductance regulator (CFTR, a Cl(-) channel) disrupt salt and fluid transport and lead to the formation of thick mucus in patients' airways. Obstruction by mucus predisposes CF patients to chronic infections and inflammation, which become gradually harder to control and eventually fatal. Aggressive antibiotic therapy and supportive measures have dramatically lengthened CF patients' lives. Here, we report that sphingomyelinases (SMase) from human respiratory pathogens strongly inhibit CFTR function. The hydrolysis of sphingomyelin by SMase makes it more difficult to activate CFTR by phosphorylation of its regulatory domain. By inhibiting CFTR currents, SMase-producing respiratory tract bacteria may not only aggravate pulmonary infection in some CF patients but may also elicit a condition, analogous to CFTR deficiency, in non-CF patients suffering from bacterial lung infection.
囊性纤维化(CF)跨膜电导调节因子(CFTR,一种氯离子通道)的众多突变会破坏盐和液体的运输,并导致患者气道中形成浓稠的黏液。黏液阻塞使CF患者易患慢性感染和炎症,这些感染和炎症逐渐变得难以控制,最终导致死亡。积极的抗生素治疗和支持性措施显著延长了CF患者的寿命。在此,我们报告来自人类呼吸道病原体的鞘磷脂酶(SMase)强烈抑制CFTR功能。SMase对鞘磷脂的水解使得通过其调节域的磷酸化激活CFTR变得更加困难。通过抑制CFTR电流,产生SMase的呼吸道细菌不仅可能加重一些CF患者的肺部感染,还可能在患有细菌性肺部感染的非CF患者中引发一种类似于CFTR缺乏的病症。